Trametinib Combined With Everolimus and Lenvatinib for Recurrent/Refractory Advanced Solid Tumors

NCT04803318 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumor, Adult
Hepatocellular Carcinoma

Interventions

DRUG: Combination of three inhibitors Trametinib, Everolimus and Lenvatinib

Sponsor

Second Affiliated Hospital of Guangzhou Medical University